Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Biomerica, Inc. Secures $2.23 Million in Private Placement
PUBLIC · BMRAAug 20, 2026•7 days ago
Amount Raised
$2.23 Million
Round Type
Post-IPO Equity
IrvineBiotechnologyHealth Care
Investors
B. Riley Principal Capital, Llc
Description
On August 20, 2026, Biomerica, Inc. entered into a Securities Purchase Agreement for a private placement. The company will issue and sell 1,393,705 shares of common stock at a price of $1.60 per share. This transaction is expected to provide gross proceeds of approximately $2.23 million.
Company Information
Company
Biomerica
Location
17571 VON KARMAN AVENUE
Irvine, California, United States
About
Biomerica, Inc. is a global biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point of care (in home and in physicians’ offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. The Company’s products are designed to enhance the health and well-being of people, while reducing total healthcare costs. Biomerica’s primary focus is on gastrointestinal and inflammatory diseases where the Company has multiple diagnostic and therapeutic products in development.
Don't miss Biomerica's next move
Get an email the moment Biomerica raises, hires an exec, or expands, usually minutes after it happens.
IrvineBiotechnologyHealth Care